The analysis revealed a significant benefit of using guaraná to alleviate cancer-related fatigue, with a standard mean difference of -0.77.
Maselli-Schoueri JH et al. · Rev Assoc Med Bras (2024)
- Pooled 5 studies, 229 cancer patients (2009-2023)
- Significant fatigue reduction (SMD -0.77, 95% CI -1.34 to -0.21; Z=2.68, p=0.007)
- High heterogeneity (I²=78%); authors call for larger prospective RCTs